Hepatic Oncology (Dec 2022)

Uncooled TATO microwave system for liver ablation

  • Eduardo Crespo,
  • Antonio Hermosín,
  • Álvaro Villalba,
  • Eduardo Daguer,
  • José Flores,
  • Javier Periañez,
  • Mario Martínez-Galdámez,
  • Ernesto Santos

DOI
https://doi.org/10.2217/hep-2022-0002
Journal volume & issue
Vol. 9, no. 4

Abstract

Read online

Aim: To evaluate the safety and efficacy of uncooled TATO microwave ablation (MWA) for primary and metastatic liver cancer. Materials & methods: This was a retrospective study on percutaneous liver ablations performed with TATO MWA. Twenty-five ablations were performed; 11 (44%) were performed for hepatocellular carcinoma, 14 (56%) for colorectal carcinoma, gastric and pancreatic metastases. Results: Adverse events were reported only in one (4%) ablation: an abscess that was observed in the ablated area and was resolved with a percutaneous drainage and antibiotic therapy. Local tumor control rate was 92% at the 3-month follow-up. Conclusion: TATO MWA was safe and effective with high reproducibility in treating primary and secondary liver cancer with satisfactory technical and clinical outcomes.

Keywords